+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Therapeutic Plasma Exchange Market by Technology, Indication, Product, End-user - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5147996
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Therapeutic Plasma Exchange Market grew from USD 792.04 million in 2023 to USD 878.53 million in 2024. It is expected to continue growing at a CAGR of 9.81%, reaching USD 1.52 billion by 2030.

Therapeutic Plasma Exchange (TPE) is a medical procedure used to treat various autoimmune and hematological disorders by removing plasma from the patient's blood and replacing it with new plasma, saline, or albumin solutions. The procedure's necessity stems from its ability to remove harmful antibodies and toxins, thereby improving patient outcomes in conditions like Guillain-Barré syndrome, myasthenia gravis, and thrombotic thrombocytopenic purpura. TPE has broad applications across neurology, hematology, and nephrology, with end-use scope encompassing hospitals, clinics, and research centers. The market for TPE is primarily driven by the increasing prevalence of autoimmune and chronic diseases, advancements in healthcare infrastructure, and rising awareness of plasma therapies. However, the high cost of procedures, potential side effects, and a lack of skilled professionals can impede growth. A significant opportunity lies in expanding market presence in emerging economies where the healthcare infrastructure is improving, and there is increasing demand for sophisticated treatment options. Collaborations between public health organizations and private firms may also foster market expansion by enhancing treatment accessibility. To capitalize on these opportunities, stakeholders should focus on strategic partnerships and localized manufacturing to reduce costs. Innovations in technology to automate or streamline TPE procedures could further bolster market growth, as would advancements that minimize adverse effects. Researching alternative plasma sources or developing synthetic alternatives could offer new revenue streams. However, navigating stringent regulatory landscapes remains a challenge that requires careful strategic planning. The market is moderately competitive, characterized by partnerships and mergers for market expansion. Companies should prioritize R&D investment to foster innovation and maintain a competitive edge. Developing training programs for healthcare professionals might also mitigate the challenge posed by a scarcity of skilled practitioners, thus facilitating market penetration.

Understanding Market Dynamics in the Therapeutic Plasma Exchange Market

The Therapeutic Plasma Exchange Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Need of Therapeutic Plasma Exchange due to Rise in Prevalence of Autoimmune and Cardiac Diseases
    • Technical Advancement in Apheresis Technologies
  • Market Restraints
    • Cost Associated with the Devices and Therapeutic Plasma Exchange Procedures
  • Market Opportunities
    • Advancement in Therapeutic Plasma Exchange Technology and its Immunomodulatory Effect in Neuromuscular Diseases
    • Surge in Demand for Therapeutic Plasma Exchange (TPE) in Pediatric Intensive Care
  • Market Challenges
    • Complications Associated with the Apheresis Procedure in TPE

Exploring Porter’s Five Forces for the Therapeutic Plasma Exchange Market

Porter’s Five Forces framework further strengthens the insights of the Therapeutic Plasma Exchange Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Therapeutic Plasma Exchange Market

External macro-environmental factors deeply influence the performance of the Therapeutic Plasma Exchange Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Therapeutic Plasma Exchange Market

The Therapeutic Plasma Exchange Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Therapeutic Plasma Exchange Market

The Therapeutic Plasma Exchange Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Key Company Profiles

The report delves into recent significant developments in the Therapeutic Plasma Exchange Market, highlighting leading vendors and their innovative profiles. These include Asahi Kasei Medical Co., Ltd., Haemonetics Corporation, CSL Behring, Kedrion Biopharma Inc., Medica S.P.A., Elastrin Therapeutics, Inc., B. Braun Melsungen AG, Pall Corporation, Medicap Clinic GmbH, Infomed SA, Terumo BCT, Inc., Qingdao Haier Biomedical Co., Ltd, Mallinckrodt PLC, Fresenius Medical Care AG & Co. KGaA, Kaneka Corporation, MEISE Medizintechnik GmbH, Nikkiso Co., Ltd., Grifols, S.A., Sb-Kawasumi Laboratories, Inc., Charles River Laboratories International, Inc., Cerus Corporation, Plasma Technologies, LLC, Miltenyi Biotec, Bio Products Laboratory Ltd., and Baxter International Inc..

Market Segmentation & Coverage

This research report categorizes the Therapeutic Plasma Exchange Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Technology
    • Centrifugation
    • Membrane Separation
  • Indication
    • Hematologic Disorders
      • Atypical Hemolytic Uremic Syndrome
      • Hyperviscosity Syndrome
      • Severe/Symptomatic Cryoglobulinemia
      • Thrombotic Thrombocytopenic Purpura
    • Metabolic Disorders
    • Neurological Disorders
      • Chronic Inflammatory Demyelinating Polyneuropathy
      • Guillain-Barré Syndrome
      • Multiple Sclerosis
      • Myasthenia Gravis
      • PANDAS
    • Renal Disorders
      • Antibody-mediated Renal Transplant Rejection
      • Goodpasture Syndrome
      • Wegener's Granulomatosis
  • Product
    • Consumables
    • Devices
  • End-user
    • Blood Collection Centers & Blood Component Providers
    • Hospitals & Transfusion Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need of Therapeutic Plasma Exchange due to Rise in Prevalence of Autoimmune and Cardiac Diseases
5.1.1.2. Technical Advancement in Apheresis Technologies
5.1.2. Restraints
5.1.2.1. Cost Associated with the Devices and Therapeutic Plasma Exchange Procedures
5.1.3. Opportunities
5.1.3.1. Advancement in Therapeutic Plasma Exchange Technology and its Immunomodulatory Effect in Neuromuscular Diseases
5.1.3.2. Surge in Demand for Therapeutic Plasma Exchange (TPE) in Pediatric Intensive Care
5.1.4. Challenges
5.1.4.1. Complications Associated with the Apheresis Procedure in TPE
5.2. Market Segmentation Analysis
5.2.1. Technology: Membrane separation are preferred selection while therapeutic plasma exchange
5.2.2. Indication: Extensive usage of therapeutic plasma exchange for life threatening hematologic disorders
5.2.3. Product: Technological advancement in consumables needs should to be compatible with their plasma exchange devices and systems
5.2.4. End-user: Blood collection centers & blood component providers are commanding larger user base and support for large scale operative treatments
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
5.5. Client Customization
6. Therapeutic Plasma Exchange Market, by Technology
6.1. Introduction
6.2. Centrifugation
6.3. Membrane Separation
7. Therapeutic Plasma Exchange Market, by Indication
7.1. Introduction
7.2. Hematologic Disorders
7.2.1. Atypical Hemolytic Uremic Syndrome
7.2.2. Hyperviscosity Syndrome
7.2.3. Severe/Symptomatic Cryoglobulinemia
7.2.4. Thrombotic Thrombocytopenic Purpura
7.3. Metabolic Disorders
7.4. Neurological Disorders
7.4.1. Chronic Inflammatory Demyelinating Polyneuropathy
7.4.2. Guillain-Barré Syndrome
7.4.3. Multiple Sclerosis
7.4.4. Myasthenia Gravis
7.4.5. PANDAS
7.5. Renal Disorders
7.5.1. Antibody-mediated Renal Transplant Rejection
7.5.2. Goodpasture Syndrome
7.5.3. Wegener's Granulomatosis
8. Therapeutic Plasma Exchange Market, by Product
8.1. Introduction
8.2. Consumables
8.3. Devices
9. Therapeutic Plasma Exchange Market, by End-user
9.1. Introduction
9.2. Blood Collection Centers & Blood Component Providers
9.3. Hospitals & Transfusion Centers
10. Americas Therapeutic Plasma Exchange Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Therapeutic Plasma Exchange Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Therapeutic Plasma Exchange Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Dr. Savage Introduces Plasma Exchange for 2024 Weight Loss
13.3.2. HealthyLongevity.clinic recently partnered with Dr. Dobri Kiprov
13.3.3. MaxWell Clinic offers Therapeutic Plasma Exchange (TPE) as a Treatment Option for Dementia, Alzheimer's, Memory Los, and Autoimmune Disease
List of Figures
FIGURE 1. THERAPEUTIC PLASMA EXCHANGE MARKET RESEARCH PROCESS
FIGURE 2. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 7. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 11. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. THERAPEUTIC PLASMA EXCHANGE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. THERAPEUTIC PLASMA EXCHANGE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. THERAPEUTIC PLASMA EXCHANGE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. THERAPEUTIC PLASMA EXCHANGE MARKET DYNAMICS
TABLE 7. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MEMBRANE SEPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ATYPICAL HEMOLYTIC UREMIC SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HYPERVISCOSITY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY SEVERE/SYMPTOMATIC CRYOGLOBULINEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY THROMBOTIC THROMBOCYTOPENIC PURPURA, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GUILLAIN-BARRÉ SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MYASTHENIA GRAVIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PANDAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ANTIBODY-MEDIATED RENAL TRANSPLANT REJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GOODPASTURE SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY WEGENER'S GRANULOMATOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HOSPITALS & TRANSFUSION CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 60. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 61. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 62. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 63. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 67. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 68. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 69. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 70. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 97. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 98. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 99. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 100. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 104. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 105. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 106. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 107. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 119. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 120. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 121. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 160. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 161. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 162. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 163. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. VIETNAM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 180. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 182. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 183. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 184. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 185. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 189. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 190. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 191. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 192. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 196. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 197. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 198. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 199. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 202. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 203. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 204. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 205. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 206. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 207. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 208. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 210. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 211. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 212. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 213. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 214. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 222. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 223. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 224. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 225. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 226. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 227. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 243. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 244. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 245. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 246. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 247. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 248. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 249. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 250. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 252. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 253. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 254. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 255. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 256. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 257. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 259. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 260. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 261. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 262. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 263. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 285. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 286. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 287. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 288. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 289. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 290. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 291. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 305. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 306. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 307. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 308. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 309. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 310. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 311. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 312. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)

Companies Mentioned

The leading players in the Therapeutic Plasma Exchange Market, which are profiled in this report, include:
  • Asahi Kasei Medical Co., Ltd.
  • Haemonetics Corporation
  • CSL Behring
  • Kedrion Biopharma Inc.
  • Medica S.P.A.
  • Elastrin Therapeutics, Inc.
  • B. Braun Melsungen AG
  • Pall Corporation
  • Medicap Clinic GmbH
  • Infomed SA
  • Terumo BCT, Inc.
  • Qingdao Haier Biomedical Co., Ltd
  • Mallinckrodt PLC
  • Fresenius Medical Care AG & Co. KGaA
  • Kaneka Corporation
  • MEISE Medizintechnik GmbH
  • Nikkiso Co., Ltd.
  • Grifols, S.A.
  • Sb-Kawasumi Laboratories, Inc.
  • Charles River Laboratories International, Inc.
  • Cerus Corporation
  • Plasma Technologies, LLC
  • Miltenyi Biotec
  • Bio Products Laboratory Ltd.
  • Baxter International Inc.

Methodology

Loading
LOADING...

Table Information